• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用先进分析技术鉴定、分离和结构确证依格列净的新型强制降解产物。

Identification, isolation, and structural characterization of novel forced degradation products of Ertugliflozin using advanced analytical techniques.

机构信息

Analytical Discovery Chemistry, Aragen Life Sciences Pvt. Ltd., IDA Nacharam, Hyderabad, 500076, India.

Department of Chemistry, GITAM School of Science, GITAM Deemed to be University, Visakhapatnam, 530045, Andhra Pradesh, India.

出版信息

Sci Rep. 2023 Jun 10;13(1):9472. doi: 10.1038/s41598-023-36289-9.

DOI:10.1038/s41598-023-36289-9
PMID:37301855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10257675/
Abstract

The research elucidates the stress degradation behavior of Ertugliflozin, which is used for the treatment of type-2 diabetics. The degradation was conducted as per ICH guidelines and Ertugliflozin is relatively stable in thermal, photolytic, neutral, and alkaline hydrolysis conditions; however, considerable degradation was detected in acid hydrolysis and oxidative hydrolysis. Degradation products were identified by ultra-high-performance liquid chromatography-mass spectrometry, isolated by semi-preparative high-performance liquid chromatography, and structural characterization using high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy. Total four degradation products were identified and isolated in acid degradation, which are degradation products 1, 2, 3, and 4. Whereas in oxidative conditions, degradation product 5 was identified. All the five degradation products formed are novel, which was not reported earlier. This is the first time documented complete structural characterization of all five degradation products by using a hyphenated analytical technique. High-resolution mass, and nuclear magnetic resonance spectroscopy were used in the present study to get concrete confirmation of degradation products structures. The current method is also used to identify degradation products with shorter runtime in the future.

摘要

本研究阐明了用于治疗 2 型糖尿病的厄格列净的稳定性降解行为。降解是按照 ICH 指南进行的,厄格列净在热、光解、中性和碱性水解条件下相对稳定;然而,在酸水解和氧化水解中检测到相当大的降解。通过超高效液相色谱-质谱联用技术鉴定降解产物,通过半制备高效液相色谱法分离,并使用高分辨率质谱和核磁共振波谱法进行结构表征。在酸降解中鉴定并分离出了四个降解产物,分别为降解产物 1、2、3 和 4。而在氧化条件下,鉴定出了降解产物 5。所有形成的五个降解产物均为新化合物,此前未有报道。这是首次使用键合分析技术对所有五个降解产物进行完整的结构表征。在本研究中,高分辨率质谱和核磁共振波谱用于获得降解产物结构的确切确认。该方法还可用于在未来识别具有更短运行时间的降解产物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/a6f61e0ac009/41598_2023_36289_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/6b66572d9f3d/41598_2023_36289_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/e01049e0e597/41598_2023_36289_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/9071a7384da4/41598_2023_36289_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/efef0a837141/41598_2023_36289_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/f57c753f1d0a/41598_2023_36289_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/d258905b30fd/41598_2023_36289_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/a6f61e0ac009/41598_2023_36289_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/6b66572d9f3d/41598_2023_36289_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/e01049e0e597/41598_2023_36289_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/9071a7384da4/41598_2023_36289_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/efef0a837141/41598_2023_36289_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/f57c753f1d0a/41598_2023_36289_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/d258905b30fd/41598_2023_36289_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5854/10257675/a6f61e0ac009/41598_2023_36289_Fig7_HTML.jpg

相似文献

1
Identification, isolation, and structural characterization of novel forced degradation products of Ertugliflozin using advanced analytical techniques.采用先进分析技术鉴定、分离和结构确证依格列净的新型强制降解产物。
Sci Rep. 2023 Jun 10;13(1):9472. doi: 10.1038/s41598-023-36289-9.
2
Identification, isolation, and structural characterization of novel forced degradation products of apixaban using advanced analytical techniques.采用先进分析技术鉴定、分离和结构确证阿哌沙班的新型强制降解产物。
J Sep Sci. 2022 Nov;45(21):3942-3954. doi: 10.1002/jssc.202200466. Epub 2022 Sep 12.
3
Analytical method development, identification, and characterization of stress degradation products of idelalisib by ultrahigh-performance liquid chromatography with photodiode array and ultrahigh-performance liquid chromatography with electrospray ionization quadrupole time-of-flight mass spectrometry studies.采用超高效液相色谱-光电二极管阵列和超高效液相色谱-电喷雾电离四极杆飞行时间质谱联用技术研究依鲁替尼的分析方法开发、鉴定和特征描述。
Rapid Commun Mass Spectrom. 2024 Jun 15;38(11):e9745. doi: 10.1002/rcm.9745.
4
Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.使用液相色谱/质谱法对马昔腾坦在各种应激条件下的降解产物进行表征。
Rapid Commun Mass Spectrom. 2018 Jul 15;32(13):1075-1084. doi: 10.1002/rcm.8138. Epub 2018 May 27.
5
Mechanism of capmatinib degradation in stress conditions including degradation product characterization using ultra-high-performance liquid chromatography-quadrupole-time of flight mass spectrometry and stability-indicating analytical method development.卡马替尼在应激条件下的降解机制,包括使用超高效液相色谱-四极杆-飞行时间质谱对降解产物进行表征以及稳定性指示分析方法的开发。
Rapid Commun Mass Spectrom. 2023 Jan 15;37(1):e9417. doi: 10.1002/rcm.9417.
6
Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.瑞格列奈及其强制降解产物的液相色谱/电喷雾电离串联质谱研究
Rapid Commun Mass Spectrom. 2018 Aug 15;32(15):1181-1190. doi: 10.1002/rcm.8151.
7
Identification of degradation products of brivaracetam using liquid chromatography quadrupole time-of-flight tandem mass spectrometry: Degradation pathway elucidation.使用液相色谱-四极杆飞行时间串联质谱法鉴定布瓦西坦的降解产物:降解途径阐明。
Rapid Commun Mass Spectrom. 2024 Jan 30;38(2):e9651. doi: 10.1002/rcm.9651.
8
LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability.基于 LC/Q-TOF-MS 的依尼西尼降解产物结构特征分析及专属性含量测定方法的建立:对化学稳定性的深入了解。
Rapid Commun Mass Spectrom. 2024 Mar 15;38(5):e9696. doi: 10.1002/rcm.9696.
9
Comprehensive study on degradation profile of firocoxib and structural elucidation of its key degradation products.非罗考昔降解特性的综合研究及其关键降解产物的结构解析
J Pharm Biomed Anal. 2023 Feb 5;224:115192. doi: 10.1016/j.jpba.2022.115192. Epub 2022 Nov 28.
10
Structural elucidation of major degradation products of milbemycin oxime drug substance using LC-MS and NMR.采用 LC-MS 和 NMR 对米尔贝肟药物物质的主要降解产物进行结构解析。
J Pharm Biomed Anal. 2022 Aug 5;217:114862. doi: 10.1016/j.jpba.2022.114862. Epub 2022 Jun 1.

引用本文的文献

1
Comparing the Greenness and Validation Metrics of Traditional and Eco-Friendly Stability-Indicating HPTLC Methods for Ertugliflozin Determination.比较传统和环保型稳定性指示高效薄层色谱法测定依格列净的绿色度和验证指标
ACS Omega. 2024 May 15;9(21):23001-23012. doi: 10.1021/acsomega.4c02399. eCollection 2024 May 28.

本文引用的文献

1
UPLC-MS/MS method for the quantification of ertugliflozin and sitagliptin in rat plasma.UPLC-MS/MS 法测定大鼠血浆中厄格列净和西他列汀的浓度。
Anal Biochem. 2019 Feb 15;567:112-116. doi: 10.1016/j.ab.2018.12.016. Epub 2018 Dec 20.
2
Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed-Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin.食物对艾托格列净及其固定剂量复方制剂(艾托格列净/西他列汀和艾托格列净/二甲双胍)的药代动力学的影响。
Clin Pharmacol Drug Dev. 2019 Jul;8(5):619-627. doi: 10.1002/cpdd.629. Epub 2018 Nov 14.
3
Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date.
恩格列净及其在2型糖尿病治疗中的潜力聚焦:迄今的证据
Drug Des Devel Ther. 2017 Oct 3;11:2905-2919. doi: 10.2147/DDDT.S114932. eCollection 2017.
4
Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management.抗糖尿病药物的临床综述:对2型糖尿病管理的启示
Front Endocrinol (Lausanne). 2017 Jan 24;8:6. doi: 10.3389/fendo.2017.00006. eCollection 2017.
5
Pharmacokinetics, metabolism, and excretion of the antidiabetic agent ertugliflozin (PF-04971729) in healthy male subjects.在健康男性受试者中抗糖尿病药物埃格列净(PF-04971729)的药代动力学、代谢和排泄。
Drug Metab Dispos. 2013 Feb;41(2):445-56. doi: 10.1124/dmd.112.049551. Epub 2012 Nov 20.